Your browser doesn't support javascript.
loading
Development of thioquinazolinones, allosteric Chk1 kinase inhibitors.
Converso, Antonella; Hartingh, Timothy; Garbaccio, Robert M; Tasber, Edward; Rickert, Keith; Fraley, Mark E; Yan, Youwei; Kreatsoulas, Constantine; Stirdivant, Steve; Drakas, Bob; Walsh, Eileen S; Hamilton, Kelly; Buser, Carolyn A; Mao, Xianzhi; Abrams, Marc T; Beck, Stephen C; Tao, Weikang; Lobell, Rob; Sepp-Lorenzino, Laura; Zugay-Murphy, Joan; Sardana, Vinod; Munshi, Sanjeev K; Jezequel-Sur, Sylvie Marie; Zuck, Paul D; Hartman, George D.
Affiliation
  • Converso A; Department of Medicinal Chemistry, Merck Research Laboratories, Merck & Co., PO Box 4, West Point, PA 19486, USA. antonella_converso@merck.com
Bioorg Med Chem Lett ; 19(4): 1240-4, 2009 Feb 15.
Article in En | MEDLINE | ID: mdl-19155174
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protein Kinases / Quinazolines / Protein Kinase Inhibitors Limits: Humans Language: En Journal: Bioorg Med Chem Lett Journal subject: BIOQUIMICA / QUIMICA Year: 2009 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protein Kinases / Quinazolines / Protein Kinase Inhibitors Limits: Humans Language: En Journal: Bioorg Med Chem Lett Journal subject: BIOQUIMICA / QUIMICA Year: 2009 Type: Article Affiliation country: United States